SOPHiA GENETICS
SOPH
32 hedge funds and large institutions have $77.2M invested in SOPHiA GENETICS in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 6 closing their positions.
115% more call options, than puts
Call options by funds: $28K | Put options by funds: $13K
39% more capital invested
Capital invested by funds: $55.5M → $77.2M (+$21.7M)
7.27% more ownership
Funds ownership: 27.52% → 34.79% (+7.3%)
11% less funds holding
Funds holding: 36 → 32 (-4)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$19.1M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$313K |
| 3 |
RI
Ridgewood Investments
Springfield,
New Jersey
|
+$136K |
| 4 |
BPCE
Bank Pictet & Cie (Europe)
Frankfurt Am Main,
Germany
|
+$113K |
| 5 |
SBCM
Silverberg Bernstein Capital Management
Armonk,
New York
|
+$42.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$561K |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
-$152K |
| 3 |
BPC
Banque Pictet & Cie
Geneva 73,
Switzerland
|
-$113K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$108K |
| 5 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$84.3K |
SOPH Hedge Fund Activity: Q1 2025 in Review
32 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q1 2025, worth a combined $77.2M — up 39% from $55.5M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of SOPH and 2 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 8 added.
The largest buyer was UBS AM, adding an estimated $19.1M. The largest seller was Millennium Management, cutting an estimated $561K.
- 32 institutional investors held SOPHiA GENETICS (SOPH) as of Q1 2025, down from 36 in Q4 2024.
- Funds reported $77.2M of SOPHiA GENETICS stock for Q1 2025, up 39% quarter-over-quarter.
- 2 funds opened new SOPHiA GENETICS positions in Q1 2025 and 6 closed out, a net change of -4 holders.
- The largest SOPHiA GENETICS buyer in Q1 2025 was UBS AM, an estimated $19.1M added.
- The largest SOPHiA GENETICS seller in Q1 2025 was Millennium Management, an estimated $561K sold.
Based on aggregated 13F filings for Q1 2025.